Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay - Wikidata - wikimedia - TriplyDB

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

http://www.wikidata.org/entity/Q27478083

about

Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins Assessment of Specific Antibodies to F Protein in Serum Samples from Chinese Hepatitis C Patients Treated with Interferon plus Ribavarin Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.

P2860

Q27480975-1CEC4C90-776B-462E-96EF-58E3E375B191 Q27487302-FA27297F-85E9-4CDA-8C86-0498CE8FF1FE Q33592250-5C338AE8-2F51-4A7D-B0B9-8BEEE4CFF1E2 Q37511219-C86C62A2-4855-4C00-AFAE-0302FC082B67 Q37961619-303B276E-C5B9-43E9-9D87-F4B2BC345952 Q42997222-2988D2B1-D80A-4319-9D48-7C1F9421BD39

P2860

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

http://www.wikidata.org/entity/Q27478083

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@ast

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@en

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@nl

type

label

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@ast

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@en

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@nl

prefLabel

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@ast

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@en

Monitoring Response to Antivir ...... ection by a Core-Antigen Assay

@nl

P1433

Q27478083-9DB56C2C-87D4-4836-ACD4-BA09CA7629D1

P1476

Q27478083-8ACBD469-E3E3-4BA5-A75A-B9EFD1B5FAAA

P2093

Q27478083-6935438D-DF61-4067-8761-0D6D936937B4

Q27478083-846E8B79-91B9-4CAA-91B9-157391808859

Q27478083-91006BA2-E3BE-408F-BF9D-4ABC07AD82D0

Q27478083-AC06734A-552E-4DB3-A6E4-6CE094886322

Q27478083-E14BDE87-4107-4B63-9F15-0921E41EFF44

P2860

Q27478083-0B011984-F47D-4894-8289-94C8B02D643E

Q27478083-34C54783-1046-4404-A49B-BD3498C59177

Q27478083-3ED54B2D-2FA0-4B9B-A431-A53A5D12356D

Q27478083-3F6A70CB-0A9D-44F2-B36A-92E12CF51780

Q27478083-548A919E-5E40-48FF-9123-3493A202A56F

Q27478083-5E245952-6993-4CED-9E75-BBBCD7614A86

Q27478083-77A4FFF0-DFE8-4243-B4C0-7756944D7A38

Q27478083-7FEA98AF-8DB5-4950-8D11-DC074C09327A

Q27478083-8342A8D7-7BDC-4874-947D-A13ABFF9DBF4

Q27478083-CD1E0ECC-86B4-4AA9-8EDB-C5A5A4DC589D

P304

Q27478083-F794329B-1EFA-4AAB-897A-7D0009A57627

P31

Q27478083-B3F258B0-24CC-41C4-A544-DC40DF919182

P356

Q27478083-A7A660E5-1BE1-4B34-A4B0-715F84277C18

P407

Q27478083-2AD6D349-EB34-4E07-841D-5A575F0AC9E6

P433

Q27478083-8A467AB1-C23A-4CEA-AECE-57FFCB3FACA4

P478

Q27478083-D4AE7497-1027-46C1-9991-439E53344064

P50

Q27478083-852F2819-AC36-4B5E-AE40-3FF51258DAC8

P577

Q27478083-7E68CE4A-D58A-4FA3-A4F9-2B76E100BB4A

P698

Q27478083-9478D72F-339E-4A4E-8F07-1D9A2BA90437

P921

Q27478083-F59E78D0-53C2-4EFC-99C2-A039FC2538C8

P932

Q27478083-9E6AD9CB-E406-4406-A199-F7DE47A83BD1

P356

JCM.41.8.3881-3884.2003

P1433

Journal of Clinical Microbiology

P1476

Monitoring response to antivir ...... ection by a core-antigen assay

@en

P2093

Agostino Cividini

http://www.w3.org/2001/XMLSchema#string

Antonella Cerino

http://www.w3.org/2001/XMLSchema#string

Chiara Rebucci

http://www.w3.org/2001/XMLSchema#string

Letizia Timo

http://www.w3.org/2001/XMLSchema#string

Milena Furione

http://www.w3.org/2001/XMLSchema#string

P2860

Virological features of hepatitis C virus infection in hemodialysis patients

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Natural history of hepatitis C.

Optimal therapy of hepatitis C.

Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison.

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

P304

3881-3884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.41.8.3881-3884.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12904409

http://www.w3.org/2001/XMLSchema#string

P921

P932

179816

http://www.w3.org/2001/XMLSchema#string